查看購物車
  • Simplified Chinese
  • English
  • Japanese
全球硬式內視鏡市場按類型、臨床用途、應用、最終用戶和地區分類－預測至2030年
市場調查報告書
商品編碼
1861054

全球硬式內視鏡市場按類型、臨床用途、應用、最終用戶和地區分類－預測至2030年

Rigid Endoscopes Market by Type (Laparoscopes, Arthroscopes, Cystoscopes), Clinical Usage (Diagnostic, Surgical), Application (Laparoscopy, Cystoscopy, Arthroscopy, Other), End User (Hospitals, ASCs, Clinics), Region - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 241 Pages | 訂單完成後即時交付

價格

全球硬式內視鏡市場預計將從 2025 年的 18.3 億美元成長到 2030 年的 23.2 億美元，預測期內複合年成長率為 4.9%。

硬式內視鏡市場的成長是由慢性病盛行率上升、微創手術需求增加以及影像和光學技術的進步所推動的。

調查範圍
調查年度 2024-2030
基準年 2024
預測期 2025-2030
考慮單位 金額（十億美元）
部分 按類型、臨床用途、應用、最終用戶和地區
目標區域 北美、歐洲、亞太地區及其他地區

新興市場醫療基礎設施的擴建、手術量的增加以及醫療旅遊的興起，為先進內視鏡解決方案的普及提供了機會。然而，病毒感染風險、缺乏適當的消毒和再處理措施以及高昂的手術費用等挑戰，可能會限制這些技術的應用，尤其是在資源匱乏的地區。

硬式內視鏡市場-IMG1

在預測期內，關節鏡細分市場預計將在硬式內視鏡市場中實現最快的成長。

硬式內視鏡市場依類型可分為腹腔鏡、泌尿系統視鏡、婦科內視鏡、關節鏡、細胞鏡、神經科學用內視鏡和其他硬式內視鏡。其中，泌尿系統內視鏡市場預計到2024年將佔據第二大市場佔有率，這主要得益於肌肉骨骼疾病盛行率的不斷上升，尤其是在全球老化人口中。世界衛生組織預測，60歲及以上人口將從2023年的11億增加到2030年的14億，將使關節相關疾病的高危險群數量大幅增加。美國疾病管制與預防中心（CDC）的報告顯示，關節炎的盛行率隨年齡成長而急劇上升，從18-34歲成年人的3.6%增至75歲及以上人口的53.9%。關節鏡為診斷和治療關節損傷提供了精準、微創的解決方案，能夠縮短復原時間，改善手術效果，進而提升患者對此手術的偏好和接受度。此外，高清影像技術的進步、手術器械的改進以及整形外科醫生對關節鏡認知的提高，進一步加速了關節鏡的應用，使其成為硬式內視鏡市場中成長最快的細分領域。

根據臨床應用，硬式內視鏡市場可分為診斷應用及手術應用兩大類。其中，預計到2024年，手術應用領域將佔據最大的市場佔有率，這主要得益於微創手術在包括泌尿系統、關節鏡、泌尿外科、婦科和耳鼻喉科在內的多個專科領域的日益普及。硬式內視鏡是這些介入性手術的核心平台，它具有卓越的光學清晰度、高解析度和4K視覺化效果，以及堅固耐用、高壓釜的設計，能夠與手術器械和手術室工作流程無縫銜接。微創手術日益偏好的原因在於其諸多優勢，例如縮短住院時間、減少術後併發症、加速病患復健以及改善臨床療效，這些優勢直接影響手術量和硬式內視鏡的市場需求。

預計在預測期內，亞太地區的硬式內視鏡市場將呈現最高的成長率。

全球硬式內視鏡市場分為五個地區：北美、歐洲、亞太、拉丁美洲以及中東和非洲。預計亞太地區在預測期內將呈現最高的成長率。這主要得益於中國和印度等人口大國醫療基礎設施的改善、醫療支出的增加以及人們對疾病早期檢測意識的提高。這些國家正大力投資以加強其診斷和手術能力，從而應對日益增多的慢性病病例，特別是癌症、肺部疾病和泌尿系統疾病。日本的全民健保體系確保了先進內視鏡手術的廣泛普及。此外，醫療旅遊的興起、政府的利好舉措以及微創技術的日益普及正在加速市場滲透，使亞太地區成為全球硬式內視鏡市場的高成長區域。

本報告對全球硬式內視鏡市場進行了分析，並按類型、臨床用途、應用、最終用戶、區域趨勢以及參與市場的公司的概況進行了細分。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章重要考察

第5章 市場概覽

  • 介紹
  • 市場動態
  • 產業趨勢
  • 影響客戶業務的趨勢/顛覆性因素
  • 定價分析
  • 價值鏈分析
  • 供應鏈分析
  • 生態系分析
  • 投資和資金籌措方案
  • 技術分析
  • 貿易分析
  • 監管分析
  • 專利分析
  • 2025-2026 年主要會議和活動
  • 波特五力分析
  • 主要相關人員和採購標準
  • 鄰近市場分析
  • 未滿足的需求/最終用戶期望
  • 人工智慧/生成式人工智慧對硬式內視鏡市場的影響
  • 2025年美國關稅對硬式內視鏡市場的影響

第6章硬式內視鏡市場（按類型分類）

  • 介紹
  • 腹腔鏡
  • 泌尿系統視鏡檢查
  • 婦科內視鏡檢查
  • 關節鏡
  • 膀胱鏡
  • 神經科學用內視鏡
  • 其他

第7章硬式內視鏡市場（依臨床應用分類）

  • 介紹
  • 外科手術
  • 診斷

第8章硬式內視鏡市場（依應用領域分類）

  • 介紹
  • 腹腔鏡
  • 泌尿系統視鏡檢查
  • 關節鏡
  • 神經科學用內視鏡
  • 其他

第9章硬式內視鏡市場（依最終用戶分類）

  • 介紹
  • 醫院
  • 門診手術中心
  • 診所
  • 其他

第10章硬式內視鏡市場（按地區分類）

  • 介紹
  • 北美洲
    • 北美宏觀經濟展望
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲宏觀經濟展望
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 亞太宏觀經濟展望
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 拉丁美洲
    • 拉丁美洲宏觀經濟展望
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 中東和非洲宏觀經濟展望
    • 海灣合作理事會國家
    • 其他

第11章 競爭格局

  • 介紹
  • 主要參與企業的策略/優勢
  • 2020-2024年收入分析
  • 2024年市佔率分析
  • 公司估值矩陣：主要參與企業，2024 年
  • 公司估值矩陣：Start-Ups/中小企業，2024 年
  • 估值和財務指標
  • 品牌/產品對比
  • 競爭場景

第12章 公司概況

  • 主要參與企業
    • OLYMPUS CORPORATION
    • KARL STORZ SE & CO. KG
    • STRYKER
    • SMITH+NEPHEW
    • B. BRAUN SE
    • MEDTRONIC
    • NIPRO
    • RICHARD WOLF GMBH
    • CONMED CORPORATION
    • ARTHREX, INC.
  • 其他公司
    • FUJIFILM CORPORATION
    • HOLOGIC, INC.
    • SHANGRAO WS MEDTECH CO., LTD.
    • ATMOS MEDIZINTECHNIK GMBH & CO. KG
    • HENKE-SASS WOLF
    • RUDOLF MEDICAL GMBH+CO. KG
    • ENDOMED SYSTEMS GMBH
    • TELEFLEX INCORPORATED
    • INTEGRATED ENDOSCOPY
    • NEOSCOPE INC.
    • ECLERIS
    • NANCHANG WOEK MEDICAL TECHNOLOGY CO., LTD
    • KASHMIR SURGICAL WORKS
    • OPTOMIC
    • HIPP ENDOSKOP SERVICE GMBH

第13章附錄

Product Code: MD 9564

The global rigid endoscopes market is projected to reach USD 2.32 billion by 2030, growing from USD 1.83 billion in 2025, at a CAGR of 4.9% during the forecast period. The growth of the rigid endoscopes market is driven by the rising prevalence of chronic diseases, increasing demand for minimally invasive surgeries, and advancements in imaging and optics technology.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD billion)
SegmentsType, Clinical Usage, Application, End User, and Region
Regions coveredNorth America, Europe, APAC, RoW

Opportunities exist in emerging markets due to the expansion of healthcare infrastructure, increasing procedural volumes, and rising medical tourism, which enable the adoption of advanced endoscopic solutions. However, market growth faces challenges from risks of viral infections, lack of proper sterilization and reprocessing, and high procedural costs, which may limit widespread adoption, particularly in resource-constrained regions.

Rigid Endoscopes Market - IMG1

The arthroscopes segment is expected to grow at the fastest rate in the rigid endoscopes market during the forecast period.

By type, the rigid endoscopes market is segmented into laparoscopes, urology endoscopes, gynecology endoscopes, arthroscopes, cytoscopes, neuroendoscopes, and other rigid endoscopes. Among these, the urology endoscopes segment accounted for the second-largest market share in 2024, owing to the increasing prevalence of musculoskeletal disorders, particularly among the aging global population. According to the WHO, the number of people aged 60 and above is projected to rise from 1.1 billion in 2023 to 1.4 billion by 2030, creating a substantial patient pool at higher risk for joint-related conditions. Age-related degenerative diseases such as osteoarthritis are becoming more common, with the CDC reporting that arthritis prevalence increases sharply with age-from 3.6% in adults aged 18-34 to 53.9% in individuals 75 and older-driving demand for minimally invasive orthopedic interventions. Arthroscopy offers a precise, less invasive solution for diagnosing and treating joint injuries, reducing recovery time, and improving surgical outcomes, which enhances patient preference and procedural adoption. Additionally, advancements in high-definition imaging, improved surgical instruments, and growing awareness among orthopedic specialists are further accelerating the adoption of arthroscopes, positioning this segment for the fastest growth within the rigid endoscopes market.

The surgical usage segment accounted for the largest share of the rigid endoscopes market in 2024.

By clinical usage, the rigid endoscopes market has been divided into diagnostic & surgical usage. Among these, the surgical usage segment accounted for the largest share of the market in 2024. This is due to the increasing adoption of minimally invasive procedures across multiple specialties, including laparoscopy, arthroscopy, urology, gynecology, and ENT. Rigid endoscopes serve as the core platform for these interventions, offering superior optical clarity, high-definition and 4K visualization, and robust, autoclavable designs that integrate seamlessly with surgical instruments and operating room workflows. The growing preference for minimally invasive surgeries is driven by benefits such as shorter hospital stays, reduced post-operative complications, faster patient recovery, and enhanced clinical outcomes, which directly influence procedure volumes and market demand for rigid scopes.

Asia Pacific is projected to grow at the highest rate in the rigid endoscopes market during the forecast period.

The global rigid endoscopes market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Among these, the Asia Pacific region is projected to grow at the highest rate during the forecast period. This is primarily due to the development of healthcare infrastructure, increasing healthcare expenditure, and rising awareness of early disease detection across populous nations such as China and India. These countries are investing heavily to enhance diagnostic and surgical capabilities, particularly to manage the rising cases of chronic diseases, such as cancer, pulmonary, and urological disorders. Japan's well-established healthcare system with universal insurance coverage ensures wide accessibility to advanced endoscopic procedures. Moreover, increasing medical tourism, favorable government initiatives, and the rising adoption of minimally invasive technologies are accelerating market penetration, making the Asia Pacific a high-growth region in the global rigid endoscopes market.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1 -40%, Tier 2 -30%, and Tier 3 -30%
  • By Designation: C-level -50%, Director level -30%, and Others -20%
  • By Region: North America -30%, Europe - 25%, Asia Pacific -20%, Latin America -15%, and Middle East & Africa -10%

Notes:

Companies are classified into tiers based on their total revenue. The tiers are as follows: Tier 1 = >USD 10.0 billion, tier 2 = USD 1.0 billion to USD 10.0 billion, and tier 3 = <USD 1.0 billion

C-level primaries include CEOs, CFOs, COOs, and VPs.

Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The players operating in the rigid endoscopes market include Olympus Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Stryker (US), Medtronic (Ireland), Smith+Nephew (UK), B Braun SE (Germany), CONMED Corporation (US), Arthrex Inc. (US), Nipro (Japan), FUJIFILM Corporation (Japan), Hologic, Inc. (US), Shangrao WS Medtech Co., Ltd (China), Henke-Sass, Wolf (Germany), RUDOLF Medical GmbH + Co. KG (Germany), EndoMed Systems GmbH (Germany), Teleflex Incorporated (US), Integrated Endoscopy (US), NeoScope, Inc. (US), Ecleris (US), Nanchang WOEK Medical Technology Co., Ltd (China), Richard Wolf GmbH. (Germany), ATMOS MedizinTechnik GmbH & Co. KG (Germany), Kashmir Surgical Works. (India), Optomic (Spain), and HIPP ENDOSKOP SERVICE GMBH (Germany)

Research Coverage

This report examines the rigid endoscopes market by type, application, end user, and region. The report also examines key factors (including drivers, restraints, opportunities, and challenges) influencing market growth and provides an in-depth analysis of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends. It forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as smaller entrants to gauge the market's pulse, which, in turn, will help them gain a larger market share. Firms purchasing the report could use one or a combination of the following strategies to strengthen their market presence.

This report provides insights into the following pointers:

  • Analysis of key drivers (increasing investments, funds, and grants by government and other organizations, growing focus of hospitals to expand endoscopic units, increasing preference for minimally invasive surgeries, rising need for endoscopy to diagnose & treat target diseases), restraints (high overhead costs of endoscopy procedures, increased risk of getting infections during endoscopic procedures), opportunities (rapidly developing healthcare sector in emerging countries), challenges (increasing number of product recalls, lack of sterilization & reprocessing)
  • Market Penetration: Complete knowledge of the spectrum of products presented by the major companies in the rigid endoscopes market
  • Product Development/Innovation: Comprehensive understanding of the forthcoming trends, research and development initiatives, and product launches within the rigid endoscopes market
  • Market Development: Complete knowledge about profitable developing regions
  • Market Diversification: Exhaustive knowledge of new goods, expanding geographies, and current changes in the rigid endoscopes industry helps to diversify the market
  • Competitive Assessment: In-depth assessment of market share, growth strategies, and product offerings of leading players like Olympus Corporation (Japan), Karl Storz SE & CO. KG (Germany), Stryker (US), Nipro (Japan), EndoMed Systems GmbH (Germany), Richard Wolf GmbH. (Germany), Ambu A/S (Denmark), Smith+Nephew (UK), and others.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key objectives of secondary research
      • 2.1.1.2 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key primary sources
      • 2.1.2.2 Key objectives of primary research
      • 2.1.2.3 Key industry insights
      • 2.1.2.4 Key data from primary sources
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
    • 2.2.2 TOP-DOWN APPROACH
    • 2.2.3 COMPANY PRESENTATIONS & PRIMARY INTERVIEWS
    • 2.2.4 DEMAND-SIDE ANALYSIS (USING RIGID ENDOSCOPES)
  • 2.3 DATA TRIANGULATION
  • 2.4 MARKET RANKING ANALYSIS
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
    • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.6.2 SCOPE-RELATED LIMITATIONS
  • 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 RIGID ENDOSCOPES MARKET OVERVIEW
  • 4.2 NORTH AMERICA: RIGID ENDOSCOPES MARKET, BY END USER AND COUNTRY
  • 4.3 RIGID ENDOSCOPES MARKET: GEOGRAPHIC MIX
  • 4.4 RIGID ENDOSCOPES MARKET: EMERGING VS. DEVELOPED ECONOMIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing preference for minimally invasive surgeries
      • 5.2.1.2 Increasing burden of chronic and lifestyle-related diseases
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High overhead costs
      • 5.2.2.2 Risk of viral infections during endoscopic procedures
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Rapidly developing healthcare sector in emerging economies
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Product recalls
      • 5.2.4.2 Lack of sterilization and reprocessing
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 ADVANCED IMAGING TECHNOLOGIES
    • 5.3.2 MINIATURIZATION AND ULTRA-SLIM DESIGNS
  • 5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
  • 5.5 PRICING ANALYSIS
    • 5.5.1 AVERAGE SELLING PRICE TREND A OF RIGID ENDOSCOPES, BY KEY PLAYER, 2022-2024
    • 5.5.2 AVERAGE PRICING TREND OF RIGID ENDOSCOPES, BY REGION, 2022-2024
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 SUPPLY CHAIN ANALYSIS
  • 5.8 ECOSYSTEM ANALYSIS
  • 5.9 INVESTMENT & FUNDING SCENARIO
  • 5.10 TECHNOLOGY ANALYSIS
    • 5.10.1 KEY TECHNOLOGIES
      • 5.10.1.1 Illumination technology
    • 5.10.2 COMPLEMENTARY TECHNOLOGIES
      • 5.10.2.1 Surgical visualization
    • 5.10.3 ADJACENT TECHNOLOGIES
      • 5.10.3.1 3D endoscopic visualization
  • 5.11 TRADE ANALYSIS
    • 5.11.1 IMPORT DATA FOR HS CODE 9018, 2019-2024
    • 5.11.2 EXPORT DATA FOR HS CODE 9018, 2019-2024
  • 5.12 REGULATORY ANALYSIS
    • 5.12.1 REGULATORY LANDSCAPE
      • 5.12.1.1 North America
        • 5.12.1.1.1 US
        • 5.12.1.1.2 Canada
      • 5.12.1.2 Europe
      • 5.12.1.3 Asia Pacific
        • 5.12.1.3.1 Japan
        • 5.12.1.3.2 China
        • 5.12.1.3.3 India
      • 5.12.1.4 Latin America
      • 5.12.1.5 Middle East & Africa
    • 5.12.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.13 PATENT ANALYSIS
    • 5.13.1 PATENT PUBLICATION TREND
    • 5.13.2 JURISDICTION AND TOP APPLICANT ANALYSIS
    • 5.13.3 LIST OF PATENTS
  • 5.14 KEY CONFERENCES & EVENTS, 2025-2026
  • 5.15 PORTER'S FIVE FORCES ANALYSIS
    • 5.15.1 THREAT OF NEW ENTRANTS
    • 5.15.2 THREAT OF SUBSTITUTES
    • 5.15.3 BARGAINING POWER OF BUYERS
    • 5.15.4 BARGAINING POWER OF SUPPLIERS
    • 5.15.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.16 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.16.2 BUYING CRITERIA
  • 5.17 ADJACENT MARKET ANALYSIS
    • 5.17.1 FLEXIBLE ENDOSCOPES MARKET
  • 5.18 UNMET NEEDS/END-USER EXPECTATIONS
  • 5.19 IMPACT OF AI/GEN AI ON RIGID ENDOSCOPES MARKET
    • 5.19.1 INTRODUCTION
    • 5.19.2 AI USE CASES
    • 5.19.3 KEY COMPANIES IMPLEMENTING AI
    • 5.19.4 FUTURE OF GENERATIVE AI ON RIGID ENDOSCOPES MARKET
  • 5.20 IMPACT OF 2025 US TARIFFS ON RIGID ENDOSCOPES MARKET
    • 5.20.1 INTRODUCTION
    • 5.20.2 KEY TARIFF RATES
    • 5.20.3 PRICE IMPACT ANALYSIS
    • 5.20.4 IMPACT ON REGION
      • 5.20.4.1 North America
      • 5.20.4.2 Europe
      • 5.20.4.3 Asia Pacific
    • 5.20.5 IMPACT ON END-USE INDUSTRY

6 RIGID ENDOSCOPES MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 LAPAROSCOPES
    • 6.2.1 RISING GLOBAL PREVALENCE OF GYNECOLOGICAL AND CANCER CONDITIONS TO PROPEL MARKET GROWTH
  • 6.3 UROLOGY ENDOSCOPES
    • 6.3.1 RISING UROLOGICAL DISORDERS AND TECHNOLOGICAL ADVANCES TO DRIVE GROWTH IN UROLOGY ENDOSCOPES SEGMENT
  • 6.4 GYNECOLOGY ENDOSCOPES
    • 6.4.1 INCREASING PREVALENCE OF GYNECOLOGICAL CANCERS AMONG WOMEN TO AID MARKET GROWTH
  • 6.5 ARTHROSCOPES
    • 6.5.1 RISING GERIATRIC POPULATION AND GROWING INCIDENCE OF ORTHOPEDIC DISEASES TO BOOST MARKET GROWTH
  • 6.6 CYSTOSCOPES
    • 6.6.1 RISING BLADDER CANCER CASES AND MINIMALLY INVASIVE BENEFITS TO DRIVE CYSTOSCOPES MARKET GROWTH
  • 6.7 NEUROENDOSCOPES
    • 6.7.1 RISING NEUROLOGICAL DISORDERS AND INVESTMENTS IN ADVANCED CARE TO DRIVE MARKET GROWTH
  • 6.8 OTHER RIGID ENDOSCOPES

7 RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE

  • 7.1 INTRODUCTION
  • 7.2 SURGICAL USAGE
    • 7.2.1 RISING ADOPTION OF MINIMALLY INVASIVE SURGERIES TO DRIVE SEGMENTAL GROWTH
  • 7.3 DIAGNOSTIC USAGE
    • 7.3.1 GROWING DEMAND FOR OFFICE-BASED ENT, GYNECOLOGY, AND UROLOGY PROCEDURES TO ACCELERATE GROWTH

8 RIGID ENDOSCOPES MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 LAPAROSCOPY
    • 8.2.1 BROAD CLINICAL APPLICABILITY AND STRONG PROCEDURAL DEMAND ACROSS DIAGNOSTIC AND THERAPEUTIC INTERVENTIONS TO AID GROWTH
  • 8.3 UROLOGY ENDOSCOPY
    • 8.3.1 RISING PREVALENCE OF URINARY TRACT DISEASES AND CANCERS TO FUEL MARKET
  • 8.4 ARTHROSCOPY
    • 8.4.1 INCREASING PREVALENCE OF ARTHRITIS AMONG AGING POPULATION TO SPUR GROWTH
  • 8.5 NEUROENDOSCOPY
    • 8.5.1 FAVORABLE GOVERNMENT AND PRIVATE SECTOR POLICIES TO SUPPORT ADOPTION OF NEUROENDOSCOPES
  • 8.6 OTHER APPLICATIONS

9 RIGID ENDOSCOPES MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 HOSPITALS
    • 9.2.1 ROBUST SURGICAL INFRASTRUCTURE AND LARGE PATIENT BASE TO FOSTER GROWTH
  • 9.3 AMBULATORY SURGERY CENTERS
    • 9.3.1 GROWING PREFERENCE FOR OUTPATIENT SURGERIES AND TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET
  • 9.4 CLINICS
    • 9.4.1 RISING ADOPTION OF OUTPATIENT DIAGNOSTICS AND DECENTRALIZED HEALTHCARE TO AID GROWTH
  • 9.5 OTHER END USERS

10 RIGID ENDOSCOPES MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 10.2.2 US
      • 10.2.2.1 US to dominate North American rigid endoscopes market during forecast period
    • 10.2.3 CANADA
      • 10.2.3.1 Rising chronic disease prevalence among aging population to drive market
  • 10.3 EUROPE
    • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 10.3.2 GERMANY
      • 10.3.2.1 Germany to dominate European rigid endoscopes market
    • 10.3.3 UK
      • 10.3.3.1 Increased aging population, high cancer prevalence, and strong healthcare infrastructure to drive market growth
    • 10.3.4 FRANCE
      • 10.3.4.1 Increase in health expenditure and high prevalence of cancer to stimulate market growth
    • 10.3.5 ITALY
      • 10.3.5.1 Increasing prevalence of chronic diseases to boost adoption
    • 10.3.6 SPAIN
      • 10.3.6.1 Rising aging population to drive market growth
    • 10.3.7 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 10.4.2 CHINA
      • 10.4.2.1 China to dominate Asia Pacific rigid endoscopes market during forecast period
    • 10.4.3 JAPAN
      • 10.4.3.1 Increasing chronic disease prevalence and rising geriatric population to drive growth
    • 10.4.4 INDIA
      • 10.4.4.1 Rising osteoarthritis and cancer prevalence to drive market growth
    • 10.4.5 AUSTRALIA
      • 10.4.5.1 Advancing healthcare infrastructure to support rigid endoscopes adoption in Australia
    • 10.4.6 SOUTH KOREA
      • 10.4.6.1 Super-aged society and high disease prevalence to drive growth in South Korean market
    • 10.4.7 REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 10.5.2 BRAZIL
      • 10.5.2.1 Brazil to account for largest share of Latin American market
    • 10.5.3 MEXICO
      • 10.5.3.1 Increasing minimally invasive procedures to support rigid endoscopes adoption
    • 10.5.4 REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 10.6.2 GCC COUNTRIES
      • 10.6.2.1 High healthcare investments and hospital expansions to drive market growth
    • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN RIGID ENDOSCOPES MARKET
  • 11.3 REVENUE ANALYSIS, 2020-2024
  • 11.4 MARKET SHARE ANALYSIS, 2024
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 11.5.5.1 Company footprint
      • 11.5.5.2 Region footprint
      • 11.5.5.3 Type footprint
      • 11.5.5.4 Application footprint
      • 11.5.5.5 End-user footprint
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 RESPONSIVE COMPANIES
    • 11.6.3 DYNAMIC COMPANIES
    • 11.6.4 STARTING BLOCKS
    • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
      • 11.6.5.1 Detailed list of key startups/SMEs
      • 11.6.5.2 Competitive benchmarking of key startups/SMEs
  • 11.7 COMPANY VALUATION & FINANCIAL METRICS
    • 11.7.1 FINANCIAL METRICS
    • 11.7.2 COMPANY VALUATION
  • 11.8 BRAND/PRODUCT COMPARISON
  • 11.9 COMPETITIVE SCENARIO
    • 11.9.1 PRODUCT LAUNCHES
    • 11.9.2 DEALS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
    • 12.1.1 OLYMPUS CORPORATION
      • 12.1.1.1 Business overview
      • 12.1.1.2 Products offered
      • 12.1.1.3 Recent developments
        • 12.1.1.3.1 Deals
      • 12.1.1.4 MnM view
        • 12.1.1.4.1 Right to win
        • 12.1.1.4.2 Strategic choices
        • 12.1.1.4.3 Weaknesses & competitive threats
    • 12.1.2 KARL STORZ SE & CO. KG
      • 12.1.2.1 Business overview
      • 12.1.2.2 Products offered
      • 12.1.2.3 Recent developments
        • 12.1.2.3.1 Product launches
        • 12.1.2.3.2 Deals
      • 12.1.2.4 MnM view
        • 12.1.2.4.1 Right to win
        • 12.1.2.4.2 Strategic choices
        • 12.1.2.4.3 Weaknesses & competitive threats
    • 12.1.3 STRYKER
      • 12.1.3.1 Business overview
      • 12.1.3.2 Products offered
      • 12.1.3.3 MnM view
        • 12.1.3.3.1 Right to win
        • 12.1.3.3.2 Strategic choices
        • 12.1.3.3.3 Weaknesses & competitive threats
    • 12.1.4 SMITH+NEPHEW
      • 12.1.4.1 Business overview
      • 12.1.4.2 Products offered
      • 12.1.4.3 MnM view
        • 12.1.4.3.1 Right to win
        • 12.1.4.3.2 Strategic choices
        • 12.1.4.3.3 Weaknesses & competitive threats
    • 12.1.5 B. BRAUN SE
      • 12.1.5.1 Business overview
      • 12.1.5.2 Products offered
      • 12.1.5.3 MnM view
        • 12.1.5.3.1 Right to win
        • 12.1.5.3.2 Strategic choices
        • 12.1.5.3.3 Weaknesses & competitive threat
    • 12.1.6 MEDTRONIC
      • 12.1.6.1 Business overview
      • 12.1.6.2 Products offered
      • 12.1.6.3 Recent developments
        • 12.1.6.3.1 Deals
    • 12.1.7 NIPRO
      • 12.1.7.1 Business overview
      • 12.1.7.2 Products offered
    • 12.1.8 RICHARD WOLF GMBH
      • 12.1.8.1 Business overview
      • 12.1.8.2 Products offered
      • 12.1.8.3 Recent developments
        • 12.1.8.3.1 Deals
    • 12.1.9 CONMED CORPORATION
      • 12.1.9.1 Business overview
      • 12.1.9.2 Products offered
    • 12.1.10 ARTHREX, INC.
      • 12.1.10.1 Business overview
      • 12.1.10.2 Products offered
  • 12.2 OTHER PLAYERS
    • 12.2.1 FUJIFILM CORPORATION
    • 12.2.2 HOLOGIC, INC.
    • 12.2.3 SHANGRAO WS MEDTECH CO., LTD.
    • 12.2.4 ATMOS MEDIZINTECHNIK GMBH & CO. KG
    • 12.2.5 HENKE-SASS WOLF
    • 12.2.6 RUDOLF MEDICAL GMBH + CO. KG
    • 12.2.7 ENDOMED SYSTEMS GMBH
    • 12.2.8 TELEFLEX INCORPORATED
    • 12.2.9 INTEGRATED ENDOSCOPY
    • 12.2.10 NEOSCOPE INC.
    • 12.2.11 ECLERIS
    • 12.2.12 NANCHANG WOEK MEDICAL TECHNOLOGY CO., LTD
    • 12.2.13 KASHMIR SURGICAL WORKS
    • 12.2.14 OPTOMIC
    • 12.2.15 HIPP ENDOSKOP SERVICE GMBH

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 RIGID ENDOSCOPES MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 STANDARD CURRENCY CONVERSION RATES, 2019-2024
  • TABLE 3 RIGID ENDOSCOPES MARKET: STUDY ASSUMPTIONS
  • TABLE 4 RIGID ENDOSCOPES MARKET: RISK ASSESSMENT
  • TABLE 5 PRODUCT RECALLS BY KEY PLAYERS, 2024-2025
  • TABLE 6 AVERAGE SELLING PRICE TREND OF RIGID ENDOSCOPES, BY KEY PLAYER, 2022-2024 (USD)
  • TABLE 7 AVERAGE SELLING PRICE TREND OF RIGID ENDOSCOPES, BY REGION, 2022-2024 (USD)
  • TABLE 8 IMPORT DATA FOR RIGID ENDOSCOPES UNDER HS CODE 9018, BY COUNTRY, 2019-2024 (USD THOUSAND)
  • TABLE 9 EXPORT DATA FOR RIGID ENDOSCOPES UNDER HS CODE 9018, BY COUNTRY, 2019-2024 (USD THOUSAND)
  • TABLE 10 CLASSIFICATION OF MEDICAL DEVICES BY US FDA
  • TABLE 11 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 12 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 13 CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODIES IN JAPAN
  • TABLE 14 NMPA MEDICAL DEVICES CLASSIFICATION
  • TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 RIGID ENDOSCOPES MARKET: LIST OF PATENTS, 2022-2025
  • TABLE 21 RIGID ENDOSCOPES MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025-DECEMBER 2026
  • TABLE 22 RIGID ENDOSCOPES MARKET: PORTER'S FIVE FORCES
  • TABLE 23 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF TOP THREE APPLICATIONS
  • TABLE 24 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
  • TABLE 25 RIGID ENDOSCOPES MARKET: UNMET NEEDS/END-USER EXPECTATIONS
  • TABLE 26 KEY COMPANIES IMPLEMENTING AI IN RIGID ENDOSCOPES MARKET
  • TABLE 27 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 28 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR RIGID ENDOSCOPES
  • TABLE 29 RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 30 LAPAROSCOPES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 31 UROLOGY ENDOSCOPES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 32 GYNECOLOGY ENDOSCOPES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 33 ARTHROSCOPES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 34 CYSTOSCOPES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 35 NEUROENDOSCOPES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 36 OTHER RIGID ENDOSCOPES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 37 RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 38 RIGID ENDOSCOPES MARKET FOR SURGICAL USAGE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 39 RIGID ENDOSCOPES MARKET FOR DIAGNOSTIC USAGE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 40 RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 41 RIGID ENDOSCOPES MARKET FOR LAPAROSCOPY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 42 RIGID ENDOSCOPES MARKET FOR UROLOGY ENDOSCOPY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 43 RIGID ENDOSCOPES MARKET FOR ARTHROSCOPY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 44 RIGID ENDOSCOPES MARKET FOR NEUROENDOSCOPY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 45 RIGID ENDOSCOPES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 46 RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 47 RIGID ENDOSCOPES MARKET FOR HOSPITALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 48 RIGID ENDOSCOPES MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 49 RIGID ENDOSCOPES MARKET FOR CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 50 RIGID ENDOSCOPES MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 51 RIGID ENDOSCOPES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 52 RIGID ENDOSCOPES MARKET, BY REGION, 2023-2030 (THOUSAND UNITS)
  • TABLE 53 NORTH AMERICA: RIGID ENDOSCOPES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 54 NORTH AMERICA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 55 NORTH AMERICA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (THOUSAND UNITS)
  • TABLE 56 NORTH AMERICA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 57 NORTH AMERICA: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 58 NORTH AMERICA: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 59 US: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 60 US: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 61 US: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 62 US: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 63 CANADA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 64 CANADA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 65 CANADA: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 66 CANADA: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 67 EUROPE: RIGID ENDOSCOPES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 68 EUROPE: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 69 EUROPE: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (THOUSAND UNITS)
  • TABLE 70 EUROPE: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 71 EUROPE: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 72 EUROPE: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 73 GERMANY: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 74 GERMANY: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 75 GERMANY: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 76 GERMANY: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 77 UK: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 78 UK: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 79 UK: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 80 UK: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 81 FRANCE: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 82 FRANCE: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 83 FRANCE: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 84 FRANCE: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 85 ITALY: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 86 ITALY: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 87 ITALY: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 88 ITALY: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 89 SPAIN: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 90 SPAIN: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 91 SPAIN: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 92 SPAIN: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 93 REST OF EUROPE: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 94 REST OF EUROPE: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 95 REST OF EUROPE: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 96 REST OF EUROPE: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 97 ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 98 ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 99 ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (THOUSAND UNITS)
  • TABLE 100 ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 101 ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 102 ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 103 CHINA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 104 CHINA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 105 CHINA: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 106 CHINA: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 107 JAPAN: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 108 JAPAN: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 109 JAPAN: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 110 JAPAN: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 111 INDIA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 112 INDIA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 113 INDIA: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 114 INDIA: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 115 AUSTRALIA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 116 AUSTRALIA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 117 AUSTRALIA: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 118 AUSTRALIA: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 119 SOUTH KOREA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 120 SOUTH KOREA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 121 SOUTH KOREA: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 122 SOUTH KOREA: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 123 REST OF ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 124 REST OF ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 125 REST OF ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 126 REST OF ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 127 LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 128 LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 129 LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (THOUSAND UNITS)
  • TABLE 130 LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 131 LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 132 LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 133 BRAZIL: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 134 BRAZIL: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 135 BRAZIL: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 136 BRAZIL: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 137 MEXICO: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 138 MEXICO: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 139 MEXICO: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 140 MEXICO: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 141 REST OF LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 142 REST OF LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 143 REST OF LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 144 REST OF LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 145 MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 146 MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 147 MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (THOUSAND UNITS)
  • TABLE 148 MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 149 MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 150 MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 151 GCC COUNTRIES: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 152 GCC COUNTRIES: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 153 GCC COUNTRIES: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 154 GCC COUNTRIES: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 155 REST OF MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 156 REST OF MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 157 REST OF MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 158 REST OF MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 159 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN RIGID ENDOSCOPES MARKET
  • TABLE 160 RIGID ENDOSCOPES MARKET: DEGREE OF COMPETITION
  • TABLE 161 RIGID ENDOSCOPES MARKET: REGION FOOTPRINT
  • TABLE 162 RIGID ENDOSCOPES MARKET: TYPE FOOTPRINT
  • TABLE 163 RIGID ENDOSCOPES MARKET: APPLICATION FOOTPRINT
  • TABLE 164 RIGID ENDOSCOPES MARKET: END-USER FOOTPRINT
  • TABLE 165 RIGID ENDOSCOPES MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
  • TABLE 166 RIGID ENDOSCOPES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS, BY TYPE AND REGION
  • TABLE 167 RIGID ENDOSCOPES MARKET: PRODUCT LAUNCHES, JANUARY 2022-SEPTEMBER 2025
  • TABLE 168 RIGID ENDOSCOPES MARKET: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 169 OLYMPUS CORPORATION: COMPANY OVERVIEW
  • TABLE 170 OLYMPUS CORPORATION: PRODUCTS OFFERED
  • TABLE 171 OLYMPUS CORPORATION: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 172 KARL STORZ SE & CO. KG: COMPANY OVERVIEW
  • TABLE 173 KARL STORZ SE & CO. KG: PRODUCTS OFFERED
  • TABLE 174 KARL STORZ SE & CO. KG: PRODUCT LAUNCHES, JANUARY 2022-SEPTEMBER 2025
  • TABLE 175 KARL STORZ SE & CO. KG: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 176 STRYKER: COMPANY OVERVIEW
  • TABLE 177 STRYKER: PRODUCTS OFFERED
  • TABLE 178 SMITH+NEPHEW: COMPANY OVERVIEW
  • TABLE 179 SMITH+NEPHEW: PRODUCTS OFFERED
  • TABLE 180 B. BRAUN SE: COMPANY OVERVIEW
  • TABLE 181 B. BRAUN SE: PRODUCTS OFFERED
  • TABLE 182 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 183 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 184 MEDTRONIC: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 185 NIPRO: COMPANY OVERVIEW
  • TABLE 186 NIPRO: PRODUCTS OFFERED
  • TABLE 187 RICHARD WOLF GMBH: COMPANY OVERVIEW
  • TABLE 188 RICHARD WOLF GMBH: PRODUCTS OFFERED
  • TABLE 189 RICHARD WOLF GMBH: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 190 CONMED CORPORATION: COMPANY OVERVIEW
  • TABLE 191 CONMED CORPORATION: PRODUCTS OFFERED
  • TABLE 192 ARTHREX, INC.: COMPANY OVERVIEW
  • TABLE 193 ARTHREX, INC.: PRODUCTS OFFERED
  • TABLE 194 FUJIFILM CORPORATION: COMPANY OVERVIEW
  • TABLE 195 HOLOGIC, INC.: COMPANY OVERVIEW
  • TABLE 196 SHANGRAO WS MEDTECH CO., LTD.: COMPANY OVERVIEW
  • TABLE 197 ATMOS MEDIZINTECHNIK GMBH & CO. KG: COMPANY OVERVIEW
  • TABLE 198 HENKE-SASS WOLF: COMPANY OVERVIEW
  • TABLE 199 RUDOLF MEDICAL GMBH + CO. KG: COMPANY OVERVIEW
  • TABLE 200 ENDOMED SYSTEMS GMBH: COMPANY OVERVIEW
  • TABLE 201 TELEFLEX INCORPORATED: COMPANY OVERVIEW
  • TABLE 202 INTEGRATED ENDOSCOPY: COMPANY OVERVIEW
  • TABLE 203 NEOSCOPE INC.: COMPANY OVERVIEW
  • TABLE 204 ECLERIS: COMPANY OVERVIEW
  • TABLE 205 NANCHANG WOEK MEDICAL TECHNOLOGY CO., LTD: COMPANY OVERVIEW
  • TABLE 206 KASHMIR SURGICAL WORKS: COMPANY OVERVIEW
  • TABLE 207 OPTOMIC: COMPANY OVERVIEW
  • TABLE 208 HIPP ENDOSKOP SERVICE GMBH: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 RIGID ENDOSCOPES MARKET SEGMENTATION & REGIONAL SCOPE
  • FIGURE 2 RIGID ENDOSCOPES MARKET: YEARS CONSIDERED
  • FIGURE 3 RIGID ENDOSCOPES MARKET: RESEARCH DESIGN
  • FIGURE 4 RIGID ENDOSCOPES MARKET: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 5 RIGID ENDOSCOPES MARKET: KEY PRIMARY SOURCES
  • FIGURE 6 RIGID ENDOSCOPES MARKET: KEY INSIGHTS FROM INDUSTRY EXPERTS
  • FIGURE 7 RIGID ENDOSCOPES MARKET: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 8 PRIMARY BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 9 RIGID ENDOSCOPES MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
  • FIGURE 10 RIGID ENDOSCOPES MARKET: TOP-DOWN APPROACH
  • FIGURE 11 IMPACT ANALYSIS OF MARKET DYNAMICS, 2025-2030
  • FIGURE 12 RIGID ENDOSCOPES MARKET: CAGR PROJECTIONS
  • FIGURE 13 RIGID ENDOSCOPES MARKET: DATA TRIANGULATION METHODOLOGY
  • FIGURE 14 RIGID ENDOSCOPES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 15 RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 16 RIGID ENDOSCOPES MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 17 RIGID ENDOSCOPES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 18 REGIONAL SNAPSHOT OF RIGID ENDOSCOPES MARKET
  • FIGURE 19 RISING REQUIREMENT FOR ENDOSCOPY TO DIAGNOSE AND TREAT TARGET DISEASES TO DRIVE MARKET GROWTH
  • FIGURE 20 US AND HOSPITALS SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN RIGID ENDOSCOPES MARKET IN 2024
  • FIGURE 21 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 22 MIDDLE EAST & AFRICA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 23 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
  • FIGURE 24 RIGID ENDOSCOPES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 25 TRENDS AND DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS IN RIGID ENDOSCOPES MARKET
  • FIGURE 26 RIGID ENDOSCOPES MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 27 RIGID ENDOSCOPES MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 28 RIGID ENDOSCOPES MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 29 RIGID ENDOSCOPES MARKET: FUNDING SCENARIO AND NUMBER OF DEALS, 2019-2023 (USD MILLION)
  • FIGURE 30 RIGID ENDOSCOPES MARKET: PATENT ANALYSIS, JANUARY 2015-SEPTEMBER 2025
  • FIGURE 31 TOP APPLICANTS FOR RIGID ENDOSCOPES, JANUARY 2015-SEPTEMBER 2025
  • FIGURE 32 RIGID ENDOSCOPES MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 33 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF TOP THREE APPLICATIONS
  • FIGURE 34 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
  • FIGURE 35 FLEXIBLE ENDOSCOPES MARKET OVERVIEW
  • FIGURE 36 AI USE CASES IN RIGID ENDOSCOPES MARKET
  • FIGURE 37 RIGID ENDOSCOPES MARKET: GEOGRAPHIC SNAPSHOT
  • FIGURE 38 NORTH AMERICA: RIGID ENDOSCOPES MARKET SNAPSHOT
  • FIGURE 39 ASIA PACIFIC: RIGID ENDOSCOPES MARKET SNAPSHOT
  • FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS IN RIGID ENDOSCOPES MARKET (2020-2024)
  • FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS IN RIGID ENDOSCOPES MARKET (2024)
  • FIGURE 42 RIGID ENDOSCOPES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 43 RIGID ENDOSCOPES MARKET: COMPANY FOOTPRINT
  • FIGURE 44 RIGID ENDOSCOPES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 45 EV/EBITDA OF KEY VENDORS
  • FIGURE 46 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 47 RIGID ENDOSCOPES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 48 OLYMPUS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 49 STRYKER: COMPANY SNAPSHOT
  • FIGURE 50 SMITH+NEPHEW: COMPANY SNAPSHOT
  • FIGURE 51 B. BRAUN SE: COMPANY SNAPSHOT
  • FIGURE 52 MEDTRONIC: COMPANY SNAPSHOT
  • FIGURE 53 NIPRO: COMPANY SNAPSHOT
  • FIGURE 54 CONMED CORPORATION: COMPANY SNAPSHOT